Arcadia Biosciences Cash Flow - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$0.69 $0 (0%) RKDA stock closing price Mar 29, 2017 (Closing)

The Arcadia Biosciences cash flow statement helps investors understand how well the company is managing its cash flows. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Arcadia Biosciences profits and Arcadia Biosciences debt. Arcadia Biosciences issued $0.02M worth of RKDA shares. The cash flow statement helps in the Arcadia Biosciences stock analysis by providing more information for evaluating changes in assets, liabilities and equities. RKDA decrease in investments stood at a negative value of $-5.3M for the latest 2016-Q4. View details of Arcadia Biosciences cash flows for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3
Arcadia Biosciences Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow0.44M0.34M0.28M0.14M0.37M0.21M0.14M0.07M0.35M0.27M
Net Increase (Decrease) in Assets Liabilities0.86M-0.01M0.11M-0.07M-0.05M0.52M0.81M1.2M-1.33M-0.08M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.26M0.8M0.49M0.26M2.52M2.2M1.93M1.92M4.53M4.03M
Arcadia Biosciences Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.23M-0.22M-0.19M-0.13M-0.14M-0.08M-0.02M-0.01M-0.14M-0.03M
Acquisition Disposition of Subsidiaires---------1.45M-1.45M
Increase (Decrease) in Investments-5.07M-0.88M12.2M10.46M-46.21M-11.29M----
Other Cash Inflow (Outflow) from Investment Activities----------
Arcadia Biosciences Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares0.44M0.42M0.27M0.13M68.58M68.39M68.25M-32.86M32.85M
Issuance (Repayment) of Debt Securities----10.2M8.87M8.87M-1.45M-1.15M-0.89M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.05M-0.04M-0.04M-0.04M-9.92M-8.34M-7.09M-1.23M-1.59M-0.01M
Arcadia Biosciences Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Arcadia Biosciences Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year23.97M16.57M2.83M5.35M------
Cash & Equivalents at Year End2.01M10.47M27.36M29.54M23.97M62.96M80M11.27M16.57M21.17M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

Arcadia Biosciences stock comparison chart provides an easy way to compare the stock price with peers along with details of Arcadia Biosciences stock price history.
The statement of cash flows can be categorized into three main sections:
  • Arcadia Biosciences has cash of $2.01M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Arcadia Biosciences stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-17.06M for RKDA.
  • Growth companies (typically most tech companies) spend heavily  on investing activities and this figure was negative at $-5.3M for RKDA stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Arcadia Biosciences earned $0.02M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.